The Associations Between Alanine Aminotransferase and Other Biochemical Parameters in Lean PCOS
- PMID: 35864417
- PMCID: PMC9988735
- DOI: 10.1007/s43032-022-01030-w
The Associations Between Alanine Aminotransferase and Other Biochemical Parameters in Lean PCOS
Abstract
To explore the associations of alanine aminotransferase in lean women of polycystic ovary syndrome (PCOS) with other biochemical parameters and the potential risk factors. This is a retrospective cohort study with lean PCOS (n = 91) and healthy controls (n = 45); we reviewed the electrical records and databases of the PCOS patients in our infertility clinic between January 2019 and September 2021; independent t-test, linear correlation analysis, and multiple linear regression were used to explore the associations. Higher levels of luteinizing hormone, total testosterone, thyroid stimulating hormone, platelet count, lymphocyte count, homocysteine, alanine aminotransferase (ALT), and uric acid were identified in lean PCOS patients, while follicle-stimulating hormone level was lower in in lean PCOS as expected (P < 0.05). Of note, the linear correlation showed that BMI, total testosterone, white blood cell count, lymphocyte count, aspartate aminotransferase, and uric acid were positively associated with alanine aminotransferase (r = 0.232, 0.318, 0.218, 0.388, 0.602, 0.353 respectively, P < 0.05). After multiple linear regression was performed, total testosterone and aspartate aminotransferase were independently and positively correlated with alanine aminotransferase in lean PCOS (B = 0.251, 0.605 respectively, P < 0.05). Higher level of ALT was identified in the lean PCOS. BMI, white blood cell count, lymphocyte count, aspartate aminotransferase, uric acid, and total testosterone were positively correlated with ALT in lean PCOS. Total testosterone and aspartate aminotransferase were independently and positively associated with ALT in lean PCOS after multiple linear regression. There might exist a potential risk of afflicting liver impairment for the lean PCOS women in the earlier period. Early examination and intervention might be necessary to prevent or delay the progression of the liver disease as soon as the diagnosis of PCOS.
Keywords: Alanine aminotransferase; Associations; Liver damage; Polycystic ovary syndrome; Total testosterone.
© 2022. The Author(s).
Conflict of interest statement
The authors declare is no competing interests.
Figures

Similar articles
-
What Do Higher Alanine Aminotransferase Levels Mean in Premature Ovarian Insufficiency?Reprod Sci. 2024 Feb;31(2):469-479. doi: 10.1007/s43032-023-01303-y. Epub 2023 Sep 18. Reprod Sci. 2024. PMID: 37723330
-
Hyperandrogenemia is independently associated with elevated alanine aminotransferase activity in young women with polycystic ovary syndrome.J Clin Endocrinol Metab. 2010 Jul;95(7):3332-41. doi: 10.1210/jc.2009-2698. Epub 2010 Apr 28. J Clin Endocrinol Metab. 2010. PMID: 20427499
-
Serum fibrinogen-like protein 1 as a novel biomarker in polycystic ovary syndrome: a case-control study.J Endocrinol Invest. 2022 Nov;45(11):2123-2130. doi: 10.1007/s40618-022-01844-0. Epub 2022 Jul 5. J Endocrinol Invest. 2022. PMID: 35790683
-
Association between the prevalence of hyperuricemia and reproductive hormones in polycystic ovary syndrome.Reprod Biol Endocrinol. 2018 Oct 25;16(1):104. doi: 10.1186/s12958-018-0419-x. Reprod Biol Endocrinol. 2018. PMID: 30359269 Free PMC article.
-
The Neurometabolic Function of the Dopamine-Aminotransferase System.Metabolites. 2025 Jan 6;15(1):21. doi: 10.3390/metabo15010021. Metabolites. 2025. PMID: 39852364 Free PMC article. Review.
Cited by
-
Risk factors for insulin resistance related to polycystic ovarian syndrome in Iranian population.Sci Rep. 2023 Jun 24;13(1):10269. doi: 10.1038/s41598-023-37513-2. Sci Rep. 2023. PMID: 37355686 Free PMC article. Clinical Trial.
References
-
- Spremović Rađenović S, Pupovac M, Andjić M, Bila J, Srećković S, Gudović A, Dragaš B, Radunović N. Prevalence, risk factors, and pathophysiology of nonalcoholic fatty liver disease (NAFLD) in women with polycystic ovary syndrome (PCOS) Biomedicines. 2022;10(1):131. doi: 10.3390/biomedicines10010131. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical